Dry AMD

Test for AMD
#Dry AMD #Geographic atrophy #Ophthalmology #PulseSight Therapeutics

Data support transferrin vectorised therapy for geographic atrophy

New data have revealed the potential of a DNA plasmid expressing human transferrin for the treatment of dry age-related macular degeneration (AMD) and geographic atrophy (GA). PulseSight Therapeutics shared the data on its lead programme PST-611 at the European Association for Vision and Eye Research (EVER)… Read More

#News

Screening patient for AMD
#Clinical research #Complement Therapeutics #Dry AMD #Gene therapy #Geographic atrophy #Ophthalmology

Non-interventional geographic atrophy study launches

Complement Therapeutics (CTx) has enrolled the first patient in its study of people diagnosed with geographic atrophy (GA).  The research will support the clinical development of CTx001, CTx’s lead gene therapy asset for the treatment of GA, by enabling the identification of patients with complement-driven AMD for future… Read More

#News

Retinitis pigmentosa
#American Academy of Ophthalmology 2022 #Dry AMD #Gene therapy #Geographic atrophy #Ophthalmology #Retinitis pigmentosa

Janssen shares ‘encouraging’ gene therapy study results

Results from Phase I/II MGT009 study into investigational gene therapy botaretigene sparoparvovec suggest sustained vision improvement in patients with X-linked retinitis pigmentosa (XLRP).  The study found treatment with botaretigene sparoparvovec had an acceptable safety profile and demonstrated encouraging improvements in retinal sensitivity, visual function and functional… Read More

#News

#Complement Therapeutics #Dry AMD #Gene therapy #Geographic atrophy #Scientific Advisory Board

Complement Therapeutics announces SAB to drive pipeline

Biotechnology company Complement Therapeutics (CTx) has formed a Clinical & Scientific Advisory Board to help accelerate the development of its pipeline of therapeutics targeting complement-mediated diseases. The company’s lead investigational product, CTx001, is a gene therapy for dry age-related macular degeneration/geographic atrophy, which is a leading cause of blindness. The… Read More

#News